AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35032204 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Gastrotuss® and Omeprazole
Number of subjects: 50
Study 32045879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW)
Number of subjects: 16
Study 32045879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34060968 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation
Number of subjects: 141
Study 34060968 — intervention group
Group type: COMPARATOR
Intervention: Center-based pulmonary rehabilitation
Number of subjects: 141
Study 32613311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation with targeted intensity
Number of subjects: 34
Study 32613311 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard rehabilitation)
Number of subjects: 34
Study 34455728 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with rose essential oil (REO), 3 drops by inhalation, three times a day for 3 days
Number of subjects: 80
Study 34455728 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 3 drops by inhalation, three times a day for 3 days
Number of subjects: 80
Study 32249917 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of malaria pigment by histopathology in ≥30% of high-powered fields
Number of subjects: 637
Study 32249917 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of malaria parasites by microscopy or LAMP
Number of subjects: 637
Study 32249917 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of malaria pigment detected by histopathology
Number of subjects: 637
Study 32927487 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 μg pills, 2 pills daily for 4 weeks)
Number of subjects: 95
Study 32927487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 32023234 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential patellar cauterization
Number of subjects: 78
Study 32023234 — intervention group
Group type: COMPARATOR
Intervention: Non-cauterized patella
Number of subjects: 78
Study 34542399 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Number of subjects: 37
Study 32482534 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant mFOLFOX6 (oxaliplatin 85 mg/m², leucovorin 400 mg/m², and 5‐FU bolus 400 mg/m² then 5FU Continuous infusion 2.4 g/m²) every two weeks for 12 cycles
Number of subjects: 198
Study 32482534 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 198
Study 32482534 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant mFOLFOX6
Number of subjects: 198
Study 33864109 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training (OT) performed twice a day
Number of subjects: 55
Study 33864109 — intervention group
Group type: COMPARATOR
Intervention: Olfactory training (OT) performed four times a day
Number of subjects: 55
Study 34360168 — intervention group
Group type: EXPERIMENTAL
Intervention: ChroPreg intervention
Number of subjects: 362
Study 34360168 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 362
Study 32375440 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine
Number of subjects: 62
Study 33733897 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental approach
Number of subjects: 790
Study 33733897 — intervention group
Group type: COMPARATOR
Intervention: Standard approach
Number of subjects: 790
Study 32969384 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion therapy (furosemide infusion at 2mg/hour and albumin at 2g/hour for three days)
Number of subjects: 30
Study 32969384 — intervention group
Group type: COMPARATOR
Intervention: Bolus therapy (intravenous albumin and furosemide as boluses)
Number of subjects: 30
Study 34424102 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus control techniques (antecedent-based condition - AC)
Number of subjects: 92
Study 34424102 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management techniques (consequent-based condition - CC)
Number of subjects: 92
Study 34424102 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (control group)
Number of subjects: 92
Study 32891678 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) with patient decision aids (PDAs)
Number of subjects: 180
Study 32891678 — intervention group
Group type: COMPARATOR
Intervention: Non-shared decision-making (non-SDM)
Number of subjects: 180
Study 32891678 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) with PDAs
Number of subjects: 180
Study 35687528 — intervention group
Group type: EXPERIMENTAL
Intervention: Delamanid
Number of subjects: 0
Study 35687528 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedaquiline
Number of subjects: 0
Study 35687528 — intervention group
Group type: EXPERIMENTAL
Intervention: Delamanid + Bedaquiline
Number of subjects: 0
Study 35687528 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 34474038 — intervention group
Group type: EXPERIMENTAL
Intervention: PTG-100 (150, 300, or 900 mg)
Number of subjects: 0
Study 34474038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34176104 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based information and coaching/support program
Number of subjects: 99
Study 34176104 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study 34256993 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional Cash Transfers (CCT)
Number of subjects: 880
Study 36345870 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative colonoscopy combined with right gastroepiploic vein preservation (RGV preserved during operation)
Number of subjects: 120
Study 36345870 — intervention group
Group type: COMPARATOR
Intervention: Control group (RGV not preserved during operation)
Number of subjects: 120
Study 36345870 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 33749997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac-Hyaluronate Conjugate (DF-HA) 30 mg, administered via intraarticular injection once every 4 weeks for 20 weeks (total of 6 injections)
Number of subjects: 440
Study 33749997 — intervention group
Group type: COMPARATOR
Intervention: Placebo (citric acid-sodium citrate buffered solution), administered via intraarticular injection once every 4 weeks for 20 weeks (total of 6 injections)
Number of subjects: 440
Study 33749997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac-Hyaluronate Conjugate (DF-HA)
Number of subjects: 440
Study 32593960 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (RAGT)
Number of subjects: 61
Study 32593960 — intervention group
Group type: COMPARATOR
Intervention: Conventional overground therapy (CT)
Number of subjects: 61
Study 32593960 — intervention group
Group type: EXPERIMENTAL
Intervention: All P‐MS
Number of subjects: 61
Study 34400361 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0
Study 35894865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 266
Study 35894865 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 266
Study 34075821 — intervention group
Group type: EXPERIMENTAL
Intervention: EG6s (eccentric contraction runtime = 6 seconds)
Number of subjects: 36
Study 34075821 — intervention group
Group type: EXPERIMENTAL
Intervention: EG3s (eccentric contraction runtime = 3 seconds)
Number of subjects: 36
Study 35101041 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive online education program for communication skills related to anxiety and depression screening and referral.
Number of subjects: 20
Study 33930610 — intervention group
Group type: EXPERIMENTAL
Intervention: Closeness-generating conversation
Number of subjects: 118
Study 33930610 — intervention group
Group type: EXPERIMENTAL
Intervention: Small talk conversation
Number of subjects: 118
Study 36085255 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 220
Study 36085255 — intervention group
Group type: COMPARATOR
Intervention: Digital version of the maternal and child health handbook
Number of subjects: 220
Study 32406579 — intervention group
Group type: EXPERIMENTAL
Intervention: Macitentan
Number of subjects: 0
Study 32406579 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study 35281951 — intervention group
Group type: EXPERIMENTAL
Intervention: Watson care theory nursing and eye muscle suture with absorbable sutures
Number of subjects: 148
Study 35281951 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 148
Study 35281951 — intervention group
Group type: EXPERIMENTAL
Intervention: Watson care theory nursing
Number of subjects: 148
Study 34169541 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold temperature (CT) leukofiltration
Number of subjects: 6894
Study 34169541 — intervention group
Group type: COMPARATOR
Intervention: Room temperature (RT) leukofiltration
Number of subjects: 6894
Study 32912051 — intervention group
Group type: EXPERIMENTAL
Intervention: SystemCHANGE™ + Activity Tracker
Number of subjects: 53
Study 32912051 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study 34292451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib (median dose 150 mg daily for a median of 22 months)
Number of subjects: 13
Study 34292451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 13
Study 33514577 — intervention group
Group type: EXPERIMENTAL
Intervention: Manubrium‐limited mini‐sternotomy
Number of subjects: 270
Study 33514577 — intervention group
Group type: COMPARATOR
Intervention: Conventional median sternotomy
Number of subjects: 270
Study 34047133 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Compound Endothelium Corneum (CCEC)
Number of subjects: 240
Study 34047133 — intervention group
Group type: COMPARATOR
Intervention: Erpixing Granules
Number of subjects: 240
Study 33755182 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality threat (MT)
Number of subjects: 86
Study 33755182 — intervention group
Group type: COMPARATOR
Intervention: Neutral control (NC)
Number of subjects: 86
Study 33755182 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning approach
Number of subjects: 86
Study 35597057 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group (pelvic floor muscle training and yoga)
Number of subjects: 91
Study 35597057 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised group (pelvic floor muscle training and yoga)
Number of subjects: 91
Study 35597057 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group
Number of subjects: 91
Study 35597057 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised group
Number of subjects: 91
Study 33558250 — intervention group
Group type: EXPERIMENTAL
Intervention: Paediatric drug RCTs published in 2017-2018
Number of subjects: 100
Study 32784188 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue in Teenagers on the InterNET, a web-based modular CFS/ME-specific cognitive behavioral therapy program supported by individualized clinical psychologist electronic consultations.
Number of subjects: 89
Study 32784188 — intervention group
Group type: COMPARATOR
Intervention: Skype-delivered activity management with a CFS/ME clinician (physiotherapist or occupational therapist).
Number of subjects: 89
Study 35909257 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 358
Study 33634851 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs)
Number of subjects: 78615
Study 33634851 — intervention group
Group type: EXPERIMENTAL
Intervention: HDACi AEDs
Number of subjects: 78615
Study 33634851 — intervention group
Group type: COMPARATOR
Intervention: Other AEDs
Number of subjects: 78615
Study 35130934 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 68
Study 35130934 — intervention group
Group type: COMPARATOR
Intervention: Theater-Based Intervention (TBI)
Number of subjects: 68
Study 34464411 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) using a dome screen during IV placement
Number of subjects: 19
Study 34464411 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VR) during IV placement
Number of subjects: 19
Study 34464411 — intervention group
Group type: COMPARATOR
Intervention: Guardian's satisfaction and rating of child's distress
Number of subjects: 19
Study 32767989 — intervention group
Group type: EXPERIMENTAL
Intervention: Video consultations with a physiotherapist
Number of subjects: 394
Study 32767989 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face consultations with a physiotherapist
Number of subjects: 394
Study 35565740 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Index Mediterranean Diet (LGIMD)
Number of subjects: 109
Study 35565740 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic activity program (ATFIS_1)
Number of subjects: 109
Study 35565740 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined activity program (ATFIS_2)
Number of subjects: 109
Study 35565740 — intervention group
Group type: EXPERIMENTAL
Intervention: LGIMD plus ATFIS_1 or ATFIS_2
Number of subjects: 109
Study 35565740 — intervention group
Group type: COMPARATOR
Intervention: Control Diet based on CREA‐AN (INRAN)
Number of subjects: 109
Study 35565740 — intervention group
Group type: EXPERIMENTAL
Intervention: LGIMD-ATFIS_1 group
Number of subjects: 109
Study 34551955 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (standard of care plus Mediterranean diet)
Number of subjects: 52
Study 34551955 — intervention group
Group type: COMPARATOR
Intervention: Standard of care for constipation (control)
Number of subjects: 52
Study 35256515 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab after chemoradiotherapy (CRT)
Number of subjects: 133
Study 35256515 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab after CRT
Number of subjects: 133
Study 35256515 — intervention group
Group type: COMPARATOR
Intervention: CRT alone
Number of subjects: 133
Study 33113295 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CoV555 2800 mg
Number of subjects: 452
Study 33113295 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CoV555 700 mg
Number of subjects: 452
Study 33113295 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CoV555 7000 mg
Number of subjects: 452
Study 33113295 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CoV555 (all doses combined)
Number of subjects: 452
Study 33113295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study 36394295 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web-based self-management system for hypertension (daily measurement of BP and pulse, reports of well-being, symptoms, lifestyle, medication intake, side effects, reminders, motivational messages) for 8 weeks
Number of subjects: 949
Study 36394295 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 949
Study 36394295 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web-based self-management system for hypertension
Number of subjects: 949
Study 35350097 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (DEX)
Number of subjects: 450
Study 35350097 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab plus Dexamethasone (TCZ+DEX)
Number of subjects: 450
Study 32469414 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone Marrow Transplant (BMT)
Number of subjects: 107
Study 36049674 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital asthma self-management (DASM) program
Number of subjects: 900
Study 36049674 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 900
Study 33549381 — intervention group
Group type: EXPERIMENTAL
Intervention: PRICE therapy (protection, rest, ice (cryotherapy at 3°C), compression (35 mm Hg), elevation)
Number of subjects: 20
Study 33549381 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 33070332 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar infliximab (CT‐P13, Inflectra)
Number of subjects: 345
Study 33070332 — intervention group
Group type: COMPARATOR
Intervention: Originator infliximab (Remicade)
Number of subjects: 345
Study 34479822 — intervention group
Group type: EXPERIMENTAL
Intervention: TOPP-Trauma
Number of subjects: 50
Study 34479822 — intervention group
Group type: COMPARATOR
Intervention: Control (educational pamphlet)
Number of subjects: 50
Study 33522094 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 180
Study 33522094 — intervention group
Group type: EXPERIMENTAL
Intervention: QUICK‐I
Number of subjects: 180
Study 33522094 — intervention group
Group type: COMPARATOR
Intervention: Control group (age and BMI matched)
Number of subjects: 180
Study 32828721 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stress
Number of subjects: 25
Study 32828721 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional stress
Number of subjects: 25
Study 32828721 — intervention group
Group type: COMPARATOR
Intervention: No stress
Number of subjects: 25
Study 32828721 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsolateral prefrontal cortex activity
Number of subjects: 25
Study 32828721 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventral striatum activity
Number of subjects: 25
Study 35850007 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion induction (guided self-compassion writing task)
Number of subjects: 67
Study 35850007 — intervention group
Group type: COMPARATOR
Intervention: Control condition (writing task to review the stress test)
Number of subjects: 67
Study 33974448 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based noise desensitization training
Number of subjects: 20
Study 33974448 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 20
Study 32586400 — intervention group
Group type: EXPERIMENTAL
Intervention: Health intervention (CHAMPION2)
Number of subjects: 196
Study 32586400 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention (STRIPES2)
Number of subjects: 196
Study 32586400 — intervention group
Group type: COMPARATOR
Intervention: Usual health services (control for STRIPES2)
Number of subjects: 196
Study 32586400 — intervention group
Group type: COMPARATOR
Intervention: Usual education services (control for CHAMPION2)
Number of subjects: 196
Study 35752581 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 105
Study 35752581 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 105
Study 35752581 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study 36123109 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 one-way educative and reminder text messages
Number of subjects: 115
Study 32646379 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 130
Study 32646379 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 130
Study 32285720 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga programs during incarceration
Number of subjects: 0
Study 32285720 — intervention group
Group type: COMPARATOR
Intervention: Matched control group (no yoga participation)
Number of subjects: 0
Study 33976542 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 100
Study 33976542 — intervention group
Group type: COMPARATOR
Intervention: Control (no TEAS)
Number of subjects: 100
Study 34615860 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (AZD1222) vaccine
Number of subjects: 153
Study 32504314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezlotoxumab (10 mg/kg single intravenous infusion)
Number of subjects: 606
Study 32504314 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 606
Study 35379484 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-modelling (VM)
Number of subjects: 24
Study 35379484 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote telementoring (RTM)
Number of subjects: 24
Study 35379484 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 33657679 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (2 mg per day at night)
Number of subjects: 164
Study 33657679 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 164
Study 36921619 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese herbal medicine (CHM)
Number of subjects: 95
Study 36921619 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture combined with CHM placebo
Number of subjects: 95
Study 36921619 — intervention group
Group type: COMPARATOR
Intervention: CHM combined with sham acupuncture
Number of subjects: 95
Study 33780573 — intervention group
Group type: EXPERIMENTAL
Intervention: CC-486 as maintenance therapy
Number of subjects: 0
Study 33780573 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax and azacitidine combination
Number of subjects: 0
Study 33780573 — intervention group
Group type: COMPARATOR
Intervention: Any therapy
Number of subjects: 0
Study 35001513 — intervention group
Group type: EXPERIMENTAL
Intervention: three good things intervention
Number of subjects: 267
Study 35001513 — intervention group
Group type: COMPARATOR
Intervention: early memories (placebo control)
Number of subjects: 267
Study 33622382 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (840 mg bid) plus dietary fiber (30 g bid)
Number of subjects: 100
Study 33622382 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (840 mg bid) plus placebo
Number of subjects: 100
Study 33622382 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo plus dietary fiber (30 g bid)
Number of subjects: 100
Study 33622382 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 100
Study 33622382 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 100
Study 35338764 — intervention group
Group type: EXPERIMENTAL
Intervention: I gel
Number of subjects: 90
Study 35338764 — intervention group
Group type: COMPARATOR
Intervention: Ambu Auragain
Number of subjects: 90
Study 35338764 — intervention group
Group type: COMPARATOR
Intervention: All devices
Number of subjects: 90
Study 33530713 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation intervention
Number of subjects: 110